You have 9 free searches left this month | for more free features.

Antigens, Neoplasm

Showing 1 - 25 of 1,154

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Yerevan

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    Jul 4, 2022

    Brain Cancer, Tumor Metastases Trial in Guangzhou (Personalized cellular vaccine)

    Completed
    • Brain Cancer
    • Neoplasm Metastases
    • Personalized cellular vaccine
    • Guangzhou, Guangdong, China
      Guangdong 999 Brain Hospital
    May 23, 2022

    Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

    Not yet recruiting
    • Neoplasms
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 16, 2023

    Liver Metastasis Colon Cancer Trial in Aarhus (RFA (radiofrequency ablation))

    Recruiting
    • Liver Metastasis Colon Cancer
    • RFA (radiofrequency ablation)
    • Aarhus, Denmark
      Aarhus University Hospital, Department of Surgery
    Nov 16, 2022

    The Myeloid Neoplasms Biology and Outcome Project

    Recruiting
    • Myeloid Neoplasm
      • Heidelberg, Baden-Württemberg, Germany
        UHHeidelberg
      Nov 21, 2022

      Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)

      Recruiting
      • Hepatocellular Carcinoma
      • +3 more
      • ECT204 T cells
      • Duarte, California
      • +1 more
      Jan 9, 2023

      Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

      Recruiting
      • Myeloproliferative Neoplasm
      • +7 more
        • Hong Kong, Hong Kong
          Department of Medicine, Queen Mary Hospital
        May 21, 2023

        Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

        Recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • CD123 targeted CAR-NK cells
        • Taiyuan, Shanxi, China
          Shanxi Bethune Hospital
        Aug 28, 2023

        Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

        Not yet recruiting
        • Advanced Malignant Solid Neoplasm
        • +2 more
        • Biopsy
        • +5 more
        • (no location specified)
        Jan 18, 2023

        Solid Tumor Trial in Adelaide (Radvax)

        Recruiting
        • Solid Tumor
        • Radvax
        • Adelaide, South Australia, Australia
          ARASMI
        Apr 8, 2023

        Liver Metastasis Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

        Recruiting
        • Liver Metastasis
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 8, 2022

        Liver Metastases, Colorectal Cancer Metastatic Trial in Shanghai (Sintilimab, Regorafenib, US/CT-guided Percutaneous

        Recruiting
        • Liver Metastases
        • Colorectal Cancer Metastatic
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 8, 2022

        Hepatic Small Vessel Neoplasm

        Not yet recruiting
        • Hepatic Small Vessel Neoplasm
        • Imaging
        • (no location specified)
        Oct 2, 2023

        Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (GNX102)

        Recruiting
        • Solid Tumor
        • +3 more
        • Los Angeles, California
        • +5 more
        Mar 7, 2022

        Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

        Recruiting
        • Hepatocellular Carcinoma
        • +3 more
        • ET140203 autologous T cell product
        • Duarte, California
        • +3 more
        Jul 1, 2022

        Tumor Microenvironment Analysis of Prostate Cancer Metastasis

        Recruiting
        • Recurrent Prostate Cancer
        • Biopsy
        • New York, New York
          Columbia University Medical Center
        Mar 22, 2022

        Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

        Recruiting
        • Neuroendocrine Neoplasm
        • Beijing, China
          Chinese PLA General Hospital
        May 25, 2023

        Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

        Recruiting
        • Iron Deficiency Anemia
        • Adelaide, South Australia, Australia
        • +8 more
        Jun 23, 2023

        Hypersensitivity Pneumonitis, Nasal Mucosal Disorder Trial in Cairo (nasal endoscopy)

        Completed
        • Hypersensitivity Pneumonitis
        • Nasal Mucosal Disorder
        • nasal endoscopy
        • Cairo, Egypt
          Kasr alainy school of medicine
        Feb 9, 2023

        Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

        Completed
        • Myelodysplastic/Myeloproliferative Neoplasm
        • +2 more
        • Decidual stromal cells (DSC)
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

        Not yet recruiting
        • HIV Seropositivity
        • +2 more
        • HIV Ag +Ab Assay Kit (Sysmex)
        • (no location specified)
        Aug 1, 2023

        Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

        Active, not recruiting
        • Breast Adenocarcinoma
        • +9 more
        • Duarte, California
        • +4 more
        Jul 16, 2022

        Role of MRS in Brain Lesions

        Not yet recruiting
        • Brain Lesion (General)
        • Mrs
        • MRS
        • (no location specified)
        Sep 30, 2022

        Minimal Residual Disease of Acute Myelogenous Leukemia or High

        Recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndrome
          • Rochester, New York
            University of Rochester Medical Center
          May 3, 2022